Dendreon Corporation: The Next Biotech Winner (SeekingAlpha via Yahoo! Finance)
Dendreon is weeks away from pioneering the '21st century medicine'... they could very well turn into the next Amgen or Genentech.

Institutional Shareholder Services and Glass Lewis Support Indevus' Acquisition of Valera Pharmaceuticals (PR Newswire via Yahoo! Finance)
Indevus Pharmaceuticals, Inc. said today that Institutional Shareholder Services and Glass Lewis & Co., two of the world's leading proxy advisory firms, both recommend that Indevus stockholders vote "FOR" the issuance of shares of Indevus common stock as part of Indevus' acquisition of Valera Pharmaceuticals, Inc.